The 14th Global Drug Delivery Formulation Summit is the leading event to look at innovative solutions and the greatest challenges in pharmaceutical development today.
Going to the summit?
The event will highlight pharmaceutical development challenges from small molecules and biologics, new technologies with concepts and case studies being presented in a number of innovative areas.
Cambridge Consultants' Tim Phillips, Principal Human Factors Expert, will be presenting on the key area for innovation in minimally invasive drug delivery.
Direct-to-Organ Drug Delivery – Opportunities, Challenges, and Ideas.
Date | 18 September 2023
Time | 10:20 – 10:50 am EST
Track | Solution Spotlights
Speakers | Tim Phillips, Principal Human Factors Expert, Cambridge Consultants
The R&D pipeline across the biopharma industry is diversifying at a rapid pace with new modalities and new classes of drugs becoming a significant part of their overall research strategy. Increasingly we are observing a need for delivering drugs locally in difficult-to-access anatomy such as heart, brain, spine, and kidneys across different therapeutic areas including oncology, CNS, autoimmune and a number of rare diseases. The preference will always be to deliver these drugs with a minimally invasive approach. Our team evaluated the challenges involved in developing device technologies and new procedures for delivering such complex drugs localized to organs, tumours or tissues and developed innovative ideas and concepts that could be deployed in specific situations. This talk will focus on a few select ideas and our thought process in the design and development of such delivery platforms and procedures.
The Westin Copley
10 Huntington Ave
Principal Human Factors Expert
Tim is a Principal Human Factors Engineer within the User Centred Design team at Cambridge Consultants, UK. He holds a MSc. in Ergonomics & Human Factors and a BEng. in Design Engineering. He has been working in medical product development for over a decade, having lead roles in the development and validation of numerous surgical, drug delivery, and acute care systems. Tim has cultivated a particular interest in the design and risk management of complex systems.
This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery.
Intravitreal Injection Syringe: It is merely a pre-filled syringe, but is it?
Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.
- 用户体验 （UX）